Login   |   Register
Cover Image

DOI: http://dx.doi.org/10.4081/idr.2011.e14

Bosentan and sildenafil in the treatment of HIV-associated pulmonary hypertension

Pierangelo Chinello, Stefania Cicalini, Andrea Cortese, Maria Paola Cicini, Nicola Petrosillo


We present the case of an HIV/HCV-coinfected patient with HIV-related pulmonary hypertension (HRPH) who experienced a good clinical and functional response to bosentan, with a subsequent switch to oral sildenafil due to increased transaminase levels. Bosentan resulted less handy in this case, probably due to both side effects and co-morbidities.


bosentan; sildenafil; HIV; pulmonary arterial hypertension

Full Text:


Submitted: 2011-08-11 17:47:31
Published: 2011-11-22 14:19:00
Search for citations in Google Scholar
Related articles: Google Scholar



Infectious Disease Reports [ISSN 2036-7430, eISSN 2036-7449] is an Open Access, peer-reviewed journal published by PAGEPress, Pavia, Italy. All credits and honors to PKP for their OJS.




© PAGEPress 2008-2013     -     PAGEPress is a registered trademark property of PAGEPress srl, Italy.     -     VAT: IT02125780185